google-site-verification: googlec7193c3de77668c9.html

FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder

[
Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years. This week, his role in a clinical trial has culminated in the first-ever U.S. Food and Drug Administration–approved therapy for severe leukocyte adhesion deficiency-I—a genetic condition characterized by recurrent infections and, often, early death.


Source link

Advertisements
Views: 3

See also  Reduced androgen levels linked to autism-associated traits

Check Also

Two-isotope imaging could guide targeted alpha therapy for metastatic prostate cancer

[ Prostate cancer is one of the most common cancers affecting men worldwide. However, planning …

Preclinical study points to a promising combined strategy for slowing the progression of type 1 diabetes

[ Mono- and combination therapies differentially enhance beta cell identity and attenuate beta cell stress …

An experimental Alzheimer’s drug shows promise targeting a different brain protein, new study shows

[ These brain scan images provided by Biogen show how high levels of Alzheimer’s-related tau …

Leave a Reply

Available for Amazon Prime